Skytrofa Injection, Powder, Lyophilized, For Solution
Product Images NDC 73362-012

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Skytrofa (NDC 73362-012). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ascendis Pharma Endocrinology, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (3 mg Cartridge Blister Pack Carton)

Skytrofa 3 mg injection, lyophilized powder for solution, label showing packaging for subcutaneous use. The box contains 4 single-dose cartridges and 6 sterile injection needles and is distributed by Ascendis Pharma, with illustrations of cartridges and needles. The label includes storage instructions, barcode, and information for use with the Skytrofa Auto-Injector kit.*

FDA Label Image

Principal Display Panel (3.6 mg Cartridge Blister Pack Carton)

Packaging label for Skytrofa 3.6 mg injection, powder, lyophilized, for solution, containing lonapegsomatropin-tcgd. The label shows a box containing 4 single-dose cartridges and 6 sterile injection needles, designed for subcutaneous use. It includes the Ascendis Pharma Endocrinology, Inc. logo and information about storage and usage, with an illustration of the cartridges and needles visible on the package.*

FDA Label Image

Principal Display Panel (4.3 mg Cartridge Blister Pack Carton)

Skytrofa 4.3 mg injection lyophilized powder carton for subcutaneous use containing lonapegsomatropin-tcgd. The box includes 4 single-dose cartridges and 6 sterile injection needles. The packaging is from Ascendis Pharma Endocrinology, Inc. and features product images, dosing information, handling instructions, and barcodes.*

FDA Label Image

Principal Display Panel (5.2 mg Cartridge Blister Pack Carton)

Skytrofa 5.2 mg injection lyophilized powder vial packaging label for subcutaneous use. The box contains 4 single-dose cartridges and 6 sterile injection needles. The manufacturer is Ascendis Pharma Endocrinology, Inc. The label includes storage instructions, refrigeration requirements, and a barcode.*

FDA Label Image

Principal Display Panel (6.3 mg Cartridge Blister Pack Carton)

Skytrofa 6.3 mg lyophilized powder injection for subcutaneous use. The carton contains 4 single-dose cartridges and 6 sterile injection needles. The label shows the active ingredient lonapegsomatropin-tcgd and specifies storage instructions, manufacturer Ascendis Pharma Endocrinology Division and distributor Ascendis Pharma, Inc. The packaging includes a barcode and areas for recording dates removed from refrigeration.*

FDA Label Image

Principal Display Panel (7.6 mg Cartridge Blister Pack Carton)

Box packaging label for Skytrofa 7.6 mg injection powder, lyophilized, for subcutaneous use. The label shows it contains 4 single-dose cartridges and 6 sterile injection needles, distributed by Ascendis Pharma, Inc. The label includes storage instructions, barcode, and a depiction of the cartridges and needles.*

FDA Label Image

Principal Display Panel (9.1 mg Cartridge Blister Pack Carton)

Packaging label for Skytrofa 9.1 mg injection, powder, lyophilized for solution by Ascendis Pharma Endocrinology, Inc. The box contains 4 single-dose cartridges and 6 sterile injection needles. The label includes product usage instructions, storage conditions, and a barcode. The packaging design features the Skytrofa logo, images of the cartridges and needles, and dosage information for subcutaneous administration.*

FDA Label Image

Principal Display Panel (11 mg Cartridge Blister Pack Carton)

Skytrofa 11 mg injection, powder, lyophilized for solution in a carton with 4 single-dose cartridges and 6 sterile injection needles. The label shows the drug name Lonapegsomatropin-tcgd for injection, manufacturer Ascendis Pharma Endocrinology, Inc., and includes storage instructions along with a barcode. The packaging also notes the needles are 0.25 mm x 4 mm (31G x 5/32"). The product is for subcutaneous use and prescription only.*

FDA Label Image

Principal Display Panel (13.3 mg Cartridge Blister Pack Carton)

Skytrofa 13.3 mg injection powder for solution in a lyophilized form, for subcutaneous use. The carton package includes 4 single-dose cartridges and 6 sterile injection needles. The label displays the product name, strength, form, dosage details, and manufacturer Ascendis Pharma Endocrinology, Inc. It also includes usage and storage instructions along with barcode and regulatory information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.